Ignite Creation Date:
2024-07-17 @ 10:54 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06500689
Status:
COMPLETED
Last Update Posted:
2024-07-15
First Post:
2024-07-08
Brief Title:
To Assess Allisartan IsoproxilSustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil
Sponsor:
Shenzhen Salubris Pharmaceuticals Co Ltd
Organization:
Shenzhen Salubris Pharmaceuticals Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2024-07-08
First Submit QC Date:
None
Study First Post Date:
2024-07-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-08
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED